Evidence map›Paper›PMID 39939990›Full record

ArticleFluids and barriers of the CNS2025

Kidins220-deficient hydrocephalus mice exhibit altered glial phenotypes and AQP4 differential regulation in the retina and optic nerve, with preserved retinal ganglion cell survival.

Jose A Fernández-Albarral, Ana Simón-García, Elena Salobrar-García, Juan J Salazar, Celia López-Menéndez, Luis S M Pajuelo, Jose A Matamoros, Rosa de Hoz, Inés López-Cuenca, Lorena Elvira-Hurtado and 6 more

Abstract read
In one paragraph

Article in Fluids and barriers of the CNS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jose A Fernández-Albarral *Ramon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, 28040, Spain.
Ana Simón-García *Instituto de Investigaciones Biomédicas Sols-Morreale (IIBM), Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), Madrid, 28029, Spain.
Elena Salobrar-GarcíaRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, 28040, Spain.
Juan J SalazarRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, 28040, Spain.
Celia López-MenéndezInstituto de Investigaciones Biomédicas Sols-Morreale (IIBM), Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), Madrid, 28029, Spain.
Luis S M PajueloInstituto de Investigaciones Biomédicas Sols-Morreale (IIBM), Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), Madrid, 28029, Spain.
Jose A MatamorosRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, 28040, Spain.
Rosa de HozRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, 28040, Spain.
Inés López-CuencaRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, 28040, Spain.
Lorena Elvira-HurtadoRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, 28040, Spain.
Lidia Sanchez-PueblaRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, 28040, Spain.
Marina P Sánchez-CarraleroInstituto de Investigaciones Biomédicas Sols-Morreale (IIBM), Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), Madrid, 28029, Spain.
Marina SanzInstituto de Investigaciones Biomédicas Sols-Morreale (IIBM), Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), Madrid, 28029, Spain.
José M RamírezRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, 28040, Spain.
Teresa IglesiasInstituto de Investigaciones Biomédicas Sols-Morreale (IIBM), Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), Madrid, 28029, Spain. tiglesias@iib.uam.es.
Ana I RamírezRamon Castroviejo Institute for Ophthalmic Research, Complutense University of Madrid, Madrid, 28040, Spain. airamirez@med.ucm.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hydrocephalus, characterized by ventriculomegaly due to cerebrospinal fluid accumulation in the cerebral ventricles, is a co-morbidity factor in several neurodevelopmental, psychiatric and neurodegenerative diseases. Aquaporin-4 (AQP4) is crucial for brain water homeostasis, with Aqp4 knockout mice showing sporadic ventriculomegaly and increased brain water content. Kinase D interacting substrate of 220 kDa (Kidins220), a transmembrane protein involved in neuronal survival, synaptic activity and neurogenesis, controls AQP4 levels in ependymocytes and brain astrocytes. Indeed, Kidins220 deficiency in mice leads to hydrocephalus by downregulating VPS35, a key component of the retromer complex, and targeting AQP4 to lysosomal degradation. Importantly, the ependymal barrier of idiopathic normal pressure hydrocephalus patients shows a similar downregulation of KIDINS220 and AQP4. In addition, pathogenic variants in the KIDINS220 gene are linked to SINO syndrome, a rare disorder characterized by spastic paraplegia, intellectual disability, nystagmus, and obesity associated with hydrocephalus and ventriculomegaly. Given the retina's structural and functional similarities to the brain, we hypothesized that Kidins220 deficiency would affect retinal water regulation. However, the diminished expression of Kidins220 and VPS35 in the retina of Kidins220-deficient hydrocephalus mice, did not cause edema or downregulate AQP4 in Müller cells. Surprisingly, there was an increase in AQP4 levels within this glial cell population. Conversely, AQP4 expression in the optic nerve astrocytes was reduced, as observed in brain astrocytes, suggesting a distinctive adaptive response to hydrocephalus in Müller glia within the Kidins220-deficient retina. Furthermore, we observed phenotypic modifications in retinal glia in Kidins220-deficient hydrocephalus mice. However, we did not find any signs of neuronal damage in the retina. Future studies using OCT and OCTA in SINO syndrome patients with ventriculomegaly will be essential in elucidating the relationship between KIDINS220 pathogenic variants, retinal alterations, papilledema, and visual function.

Indexed as

Aquaporin 4HydrocephalusMembrane ProteinsNerve Tissue ProteinsNeurogliaOptic NerveRetinaRetinal Ganglion CellsAnimalsCell SurvivalDisease Models, AnimalMiceMice, KnockoutPhenotypeVesicular Transport ProteinsAqp4 protein, mouseAquaporin 4Membrane ProteinsNerve Tissue ProteinsVesicular Transport ProteinsVps35 protein, mouseAQP4Astrocyte hypertrophyHydrocephalusKidins220OCTOCT angiographyOptic nervePhagocytic MicrogliaRetinaSNX27-retromerVentriculomegalyVPS35

Identifiers

PMID39939990
PMCPMC11823095

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.